Risk Stratification of Patients with AECOPD Brian H. Rowe Chronic Obstructive Pulmonary Disease (G Volturo, Section Editor) 14 September 2013 Pages: 181 - 188
Effectiveness of Inhaled Steroids in the Management of Chronic Obstructive Pulmonary Disease Charles L. Emerman Chronic Obstructive Pulmonary Disease (G Volturo, Section Editor) 22 August 2013 Pages: 189 - 192
Strategies for Avoiding Hospitalization of Patients with AECOPD Sean P. O’Reilly Chronic Obstructive Pulmonary Disease (G Volturo, Section Editor) 16 October 2013 Pages: 193 - 199
Reversal of Novel Anticoagulants: Role of Clotting Factors and Complex Concentrates A. Josh RobertsMark E. SutterWilliam E. Dager Pharmacology of Acute Care (J Fanikos, Section Editor) 27 September 2013 Pages: 200 - 207
Measuring or Monitoring of Novel Anticoagulants: Which Laboratory Test to Request? Paul P. DobeshKimberly J. Terry Pharmacology of Acute Care (J Fanikos, Section Editor) 05 October 2013 Pages: 208 - 216
Renaissance of Aspirin for the Primary and Secondary Prevention of Venous Thromboembolism Allison E. BurnettLinda R. KellyCharles E. Mahan Pharmacology of Acute Care (J Fanikos, Section Editor) 15 October 2013 Pages: 217 - 225
Biosimilars: An Emerging Category of Biologic Drugs for Emergency Medicine Practitioners Katelyn SylvesterMegan RocchioJohn Fanikos Pharmacology of Acute Care (J Fanikos, Section Editor) 11 September 2013 Pages: 226 - 235
Submassive Pulmonary Embolism: Risk Evaluation and Role of Fibrinolysis Rathasen PromRyan DullJohn Fanikos Pharmacology of Acute Care (J Fanikos, Section Editor) 28 September 2013 Pages: 236 - 246